|
Original Artikel |
Datum |
Titel |
Autoren Alle Autoren |
1 |
[GO] |
2025―Mrz―13 |
Characterization of the binding features between SARS-CoV-2 5’-proximal transcripts of genomic RNA and nucleocapsid proteins |
Shih-Cheng Chen, Cui-Ting Xu, Chuan-Fu Chang, Chia-Shin Yang, Pin-Han Lin, Wei-Min Liu, et al. (+2) Yeh Chen, Chien-Hung Yu |
2 |
[GO] |
2024―Dez―04 |
Decoding the genome of SARS-CoV-2: a pathway to drug development through translation inhibition |
Shan-Na Wu, Ting Xiao, Hui Chen, Xiao-Hong Li |
3 |
[GO] |
2024―Mrz―01 |
An elusive debate on the evidence for RNA editing in SARS-CoV-2 |
Giorgio Mattiuz, Salvatore Di Giorgio, Silvestro G. Conticello |
4 |
[GO] |
2023―Aug―02 |
SNHG15 aids SARS-CoV-2 entry via RABL2A |
Samuel Pushparaj, Chaitanya Gandikota, Kishore Vaddadi, Yurong Liang, Lin Liu |
5 |
[GO] |
2023―Jul―07 |
SARS-CoV-2 Nsp1 mediated mRNA degradation requires mRNA interaction with the ribosome |
Soraya I. Shehata, Roy Parker |
6 |
[GO] |
2023―Jun―05 |
Biochemistry-informed design selects potent siRNAs against SARS-CoV-2 |
Élisabeth Houbron, Sophie Mockly, Sophia Rafasse, Nathalie Gros, Delphine Muriaux, Hervé Seitz |
7 |
[GO] |
2023―Mai―18 |
The continuing discovery on the evidence for RNA editing in SARS-CoV-2 |
Xiaoxin Pu, Qinwei Xu, Jinxiang Wang, Baoyi Liu |
8 |
[GO] |
2022―Aug―08 |
Thrombosis-related circulating miR-16-5p is associated with disease severity in patients hospitalised for COVID-19 |
Ceren Eyileten, Zofia Wicik, Sérgio N. Simões, David C. Martins-Jr, Krzysztof Klos, Wojciech Wlodarczyk, et al. (+5) Alice Assinger, Dariusz Soldacki, Andrzej Chcialowski, Jolanta M. Siller-Matula, Marek Postula |
9 |
[GO] |
2022―Jun―28 |
Evidence for selection on SARS-CoV-2 RNA translation revealed by the evolutionary dynamics of mutations in UTRs and CDSs |
Lin Zhu, Qi Wang, Weiyu Zhang, Hao Hu, Kexin Xu |
10 |
[GO] |
2021―Dez―14 |
Cellular miR-150-5p may have a crucial role to play in the biology of SARS-CoV-2 infection by regulating nsp10 gene |
S. M. Akula, Paul Bolin, Paul P. Cook |
11 |
[GO] |
2021―Nov―18 |
Nsp1 of SARS-CoV-2 stimulates host translation termination |
Alexey Shuvalov, Ekaterina Shuvalova, Nikita Biziaev, Elizaveta Sokolova, Konstantin Evmenov, Nikolay Pustogarov, et al. (+4) Aleksandra Arnautova, Vera Matrosova, Tatiana Egorova, Elena Alkalaeva |
12 |
[GO] |
2021―Mai―09 |
A DNA intercalating dye-based RT-qPCR alternative to diagnose SARS-CoV-2 |
Federico Fuchs Wightman, Micaela A. Godoy Herz, Juan C. Muñoz, José N. Stigliano, Laureano Bragado, Nicolas Nieto Moreno, et al. (+18) Marcos Palavecino, Lucas Servi, Gonzalo Cabrerizo, José Clemente, Martín Avaro, Andrea Pontoriero, Estefanía Benedetti, Elsa Baumeister, Fabian Rudolf, Federico Remes Lenicov, Cybele Garcia, Valeria Buggiano, Alberto R. Kornblihtt, Anabella Srebrow, Manuel de la Mata, Manuel J. Muñoz, Ignacio E. Schor, Ezequiel Petrillo |
13 |
[GO] |
2021―Feb―03 |
Peripheral blood microRNAs and the COVID-19 patient: methodological considerations, technical challenges and practice points |
Lucía Pinilla, Ivan D. Benitez, Jessica González, Gerard Torres, Ferran Barbé, David de Gonzalo-Calvo |
14 |
[GO] |
2020―Sep―23 |
Secondary structure of the SARS-CoV-2 5’-UTR |
Zhichao Miao, Antonin Tidu, Gilbert Eriani, Franck Martin |